A hearing on whether local biotech firm TransGenRx will be able to auction its remaining assets has been reset for Nov. 6 in U.S. Bankruptcy Court in Baton Rouge.

The hearing was originally scheduled for Friday, but Judge Douglas Dodd postponed the hearing. Potential buyer ProteoVec LLC has offered $400,000 for TransGenRx’s intellectual property and equipment.

TransGenRx sought bankruptcy court protection in May, but the company has been unable to find new financing.